Great news from our portfolio company InSphero, the global market leader in 3D spheroids and cell-based assays for pharmaceutical drug discovery and safety testing.
The company has announced the successful completion of an eight-figure financing round led by ZEISS Ventures and with participation from existing and new investors.
The funds are used to advance the development and availability of cryopreserved assay-ready plates for 3D spheroid assays, enabling laboratories to store these plates for rapid access, thereby streamlining research and drug development processes. For ZEISS Ventures it is as a strategic investment closely linked to ZEISS Research Microscopy Solutions.
More information in the press release under the following Link
More about InSphero
